High blood soluble receptor p80 for tumour necrosis factor-α is associated with erythropoietin resistance in haemodialysis patients

Nephrology Dialysis Transplantation

Volumn 16, Issue 9, 2001, Pages 1838-1844

  Kato, Akihiko ^a   Odamaki, Mari ^a   Takita, Takako ^b   Furuhashi, Mitsuyoshi ^b   Maruyama, Yukitaka ^b   Hishida, Akira ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Maruyama Hospital   (Japan)

Author keywords

Erythropoietin; Female; Interleukin 6; Resistance; Soluble TNF receptor

Indexed keywords

ALBUMIN; BIOLOGICAL MARKER; C REACTIVE PROTEIN; CREATININE; CYTOKINE; FERRITIN; HEMOGLOBIN; INTERLEUKIN 6; PARATHYROID HORMONE; PROTEIN P55; PROTEIN P80; RECOMBINANT ERYTHROPOIETIN; SOLUBLE TUMOR NECROSIS FACTOR ALPHA RECEPTOR; TUMOR NECROSIS FACTOR ALPHA; TUMOR NECROSIS FACTOR ALPHA RECEPTOR; UNCLASSIFIED DRUG;

ADULT; AGED; ANEMIA; ARTICLE; BLOOD LEVEL; BODY MASS; CONTROLLED STUDY; DRUG RESISTANCE; ERYTHROPOIESIS; FEMALE; HEMODIALYSIS PATIENT; HEMOGLOBIN DETERMINATION; HUMAN; IN VITRO STUDY; INFLAMMATION; LONG TERM CARE; MAJOR CLINICAL STUDY; MALE; MUSCLE MASS; OUTPATIENT; PREDICTION; PRIORITY JOURNAL; REGRESSION ANALYSIS; SEX DIFFERENCE;

EID: 0034839119     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/ndt/16.9.1838     Document Type: Article

References (23)

1. Early prediction of response to recombinant human erythropoietin in patients with anemia of renal failure by serum transferrin receptor and fibrinogen
2. High C-reactive protein is a strong predictor of resistance to erythropoietin in hemodialysis patients
3. Acute-phase response predicts erythropoietin resistance in hemodialysis and peritoneal dialysis patients
4. Plasma levels of IL-1β, TNFα and their specific inhibitors in undialyzed chronic renal failure. CAPD and hemodialysis patients
5. TNF-α: mRNA, plasma protein levels and soluble receptors in patients on chronic hemodialysis, on CAPD and with end-stage renal failure
6. New method to calculate creatinine generation rate using pre- and postdialysis creatinine concentrations
7. Tumor necrosis factor alpha and the anemia of chronic disease: Effects of chronic exposure to TNF on erythropoiesis in vivo
8. Erythropoietin fails to reverse the anemia in mice continuously exposed to tumor necrosis factor-alpha in vivo
9. Bifunctional effects of tumor necrosis factor α (TNFα) on the growth of mature and primitive human hematopoietic progenitor cells: Involvement of p55 and p75 TNF receptors
10. Role of the 75-kDa tumor necrosis factor receptor: Inhibition of early hematopoiesis
11. Inadequate erythropoietin response to anaemia in HIV patients: Relationship to serum levels of tumour necrosis factor-alpha, interleukin-6 and their soluble receptors
12. Anaemia of chronic disease in rheumatoid arthritis: In vivo effects of tumour necrosis factor alpha blockade
13. Management of anaemia in United Kingdom renal units: A report from the UK Renal Registry
14. Serum interleukin-6 levels are useful indicators of marrow suppression in patients with resistance to erythropoietin due to inflammatory disease
15. Role of cytokines in the response to erythropoietin in hemodialysis patients
16. IL-6-induced anaemia in rats: Possible pathogenic implications for anaemia observed in chronic inflammations
17. R-HuEpo hyporesponsiveness-who and why?
18. Production of soluble tumor necrosis factor receptors by human subcutaneous adipose tissue in vivo
19. Dialysate related cytokine induction and response to recombinant human erythropoietin in haemodialysis patients
20. The association between hypoalbuminemia and soluble receptor for tumor necrosis factor (sTNFR) in patients with hemodialysis (HD)
21. C-reactive protein as an outcome predictor for maintenance hemodialysis patients
22. Inflammatory mediators in children with protein-energy malnutrition
23. Mechanisms of host wasting induced by administration of cytokines in rats